Global improvement of cardiovascular outcomes |
42, 89, 90 |
1, 2, 91–93 |
Favorable carotid artery disease status |
94–96 |
91, 92 |
Improved insulin resistance |
97–99 |
100 |
Reduced procoagulant activity |
101–104 |
105–107 |
Improved vasomotor function |
76, 80, 108 |
109–111 |
Amelioration of postischemic reperfusion injury |
112 |
113 |
Improved myocardial perfusion |
114 |
115 |
Improved outcome following coronary artery procedures |
112, 114, 116, 117 |
115, 118, 119 |
Amelioration of cardiac arrhythmias |
120, 121 |
122, 123 |
Improved myocardial function in cardiomyopathy |
120 |
124 |
Lower high-sensitivity C-reactive protein levels |
37–39, 89 |
29, 100 |
Lower ferritin levels |
42, 43, 89, 90 |
37–41 |